NDUFA5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.214400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.093600E-01
Normal-vs-Stage2
9.654800E-01
Normal-vs-Stage3
5.546400E-01
Normal-vs-Stage4
7.645000E-01
Stage1-vs-Stage2
6.294500E-02
Stage1-vs-Stage3
7.284400E-02
Stage1-vs-Stage4
2.840200E-01
Stage2-vs-Stage3
5.582000E-01
Stage2-vs-Stage4
7.829600E-01
Stage3-vs-Stage4
4.012400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.127600E-01
Normal-vs-AfricanAmerican
7.102400E-01
Normal-vs-Asian
8.047600E-01
Caucasian-vs-AfricanAmerican
9.525600E-01
Caucasian-vs-Asian
2.348400E-01
AfricanAmerican-vs-Asian
4.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.283800E-01
Normal-vs-Female
8.026800E-01
Male-vs-Female
9.008400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.367000E-01
Normal-vs-Age(41-60Yrs)
6.733600E-01
Normal-vs-Age(61-80Yrs)
9.403800E-01
Normal-vs-Age(81-100Yrs)
9.102000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.185600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.709600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.331200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.254160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.734100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.557800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.195600E-01
Normal-vs-Daily Drinker
7.431200E-01
Normal-vs-Weekly Drinker
5.958400E-01
Normal-vs-Occasional Drinker
5.979400E-01
Normal-vs-Social Drinker
6.525000E-01
Non Drinker-vs-Daily Drinker
1.879590E-01
Non Drinker-vs-Weekly Drinker
9.305400E-01
Non Drinker-vs-Occasional Drinker
6.852100E-02
Non Drinker-vs-Social Drinker
1.977180E-01
Daily Drinker-vs-Weekly Drinker
2.076000E-01
Daily Drinker-vs-Occasional Drinker
9.982400E-01
Daily Drinker-vs-Social Drinker
6.823600E-01
Weekly Drinker-vs-Occasional Drinker
8.405600E-02
Weekly Drinker-vs-Social Drinker
2.091800E-01
Occasional Drinker-vs-Social Drinker
6.719400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.053600E-01
Normal-vs-Grade 2
5.432200E-04
Normal-vs-Grade 3
3.544100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.627800E-02
Grade 1-vs-Grade 3
4.776500E-02
Grade 1-vs-Grade 4
2.053600E-01
Grade 2-vs-Grade 3
3.652400E-01
Grade 2-vs-Grade 4
5.432200E-04
Grade 3-vs-Grade 4
3.544100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.620400E-01
Normal-vs-NonDiabetic
7.884200E-01
Diabetic-vs-NonDiabetic
1.059620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.970400E-01
Normal-vs-NoPancreatitis
8.486400E-01
Pancreatitis-vs-NoPancreatitis
2.668200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.793200E-01
Normal-vs-N1
9.509800E-01
N0-vs-N1
1.632590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.931400E-01
Normal-vs-TP53-NonMutant
6.397000E-01
TP53-Mutant-vs-TP53-NonMutant
9.893900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
